Burden of disease predicts response to isolated limb infusion with melphalan and actinomycin D in melanoma.
about
The Role of Regional Therapies for in-Transit Melanoma in the Era of Improved Systemic Options.Clinical Response and Regional Toxicity Following Isolated Limb Infusion Compared with Isolated Limb Perfusion for In-Transit Melanoma.Australian Multicenter Study of Isolated Limb Infusion for Melanoma.Isolated Limb Infusion: A Single-Center Experience with Over 200 Infusions.Outcomes and Predictive Factors of Isolated Limb Infusion for Patients with In-transit Melanoma in China.Safety and Efficacy of Isolated Limb Infusion Chemotherapy for Advanced Locoregional Melanoma in Elderly Patients: An Australian Multicenter Study.
P2860
Burden of disease predicts response to isolated limb infusion with melphalan and actinomycin D in melanoma.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Burden of disease predicts res ...... and actinomycin D in melanoma.
@ast
Burden of disease predicts res ...... and actinomycin D in melanoma.
@en
type
label
Burden of disease predicts res ...... and actinomycin D in melanoma.
@ast
Burden of disease predicts res ...... and actinomycin D in melanoma.
@en
prefLabel
Burden of disease predicts res ...... and actinomycin D in melanoma.
@ast
Burden of disease predicts res ...... and actinomycin D in melanoma.
@en
P2093
P2860
P1476
Burden of disease predicts res ...... and actinomycin D in melanoma.
@en
P2093
Diego J Muilenburg
Douglas S Tyler
Ji-Hyun Lee
Jonathan S Zager
Zachary J Thompson
P2860
P2888
P304
P356
10.1245/S10434-014-4072-0
P577
2014-09-06T00:00:00Z
P6179
1044895996